CA2485545A1 - (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition - Google Patents
(r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition Download PDFInfo
- Publication number
- CA2485545A1 CA2485545A1 CA002485545A CA2485545A CA2485545A1 CA 2485545 A1 CA2485545 A1 CA 2485545A1 CA 002485545 A CA002485545 A CA 002485545A CA 2485545 A CA2485545 A CA 2485545A CA 2485545 A1 CA2485545 A1 CA 2485545A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- ethyl
- benzimidazole
- amidinophenylaminomethyl
- pyrrolidinocarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10227666.8 | 2002-06-20 | ||
DE10227666A DE10227666A1 (de) | 2002-06-20 | 2002-06-20 | (R)-2-(4-Amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1-(pyrrolidinocarbonyl)- ethyl]-benzimidazol, dessen Monohydrochlorid, Verfahren zu deren Herstellung sowie Verwendung als Arzneimittel |
PCT/EP2003/006317 WO2004000818A1 (de) | 2002-06-20 | 2003-06-16 | Kristallines (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazol sowie dessen verwendung als antithrombosemittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2485545A1 true CA2485545A1 (en) | 2003-12-31 |
Family
ID=29719306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002485545A Abandoned CA2485545A1 (en) | 2002-06-20 | 2003-06-16 | (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1529035A1 (ja) |
JP (1) | JP2006508037A (ja) |
AR (1) | AR040445A1 (ja) |
AU (1) | AU2003237945A1 (ja) |
CA (1) | CA2485545A1 (ja) |
DE (1) | DE10227666A1 (ja) |
TW (1) | TW200413329A (ja) |
UY (1) | UY27856A1 (ja) |
WO (1) | WO2004000818A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103403018B (zh) | 2010-12-21 | 2015-08-19 | 医药公司(莱比锡)有限公司 | 胰蛋白酶样丝氨酸蛋白酶抑制剂,它们的制备以及作为凝结因子IIa和Xa的选择性抑制剂的用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI248435B (en) * | 1998-07-04 | 2006-02-01 | Boehringer Ingelheim Pharma | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
DE19962329A1 (de) * | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel |
-
2002
- 2002-06-20 DE DE10227666A patent/DE10227666A1/de not_active Withdrawn
-
2003
- 2003-06-16 JP JP2004514726A patent/JP2006508037A/ja active Pending
- 2003-06-16 EP EP03735629A patent/EP1529035A1/de not_active Withdrawn
- 2003-06-16 CA CA002485545A patent/CA2485545A1/en not_active Abandoned
- 2003-06-16 AU AU2003237945A patent/AU2003237945A1/en not_active Abandoned
- 2003-06-16 WO PCT/EP2003/006317 patent/WO2004000818A1/de active Application Filing
- 2003-06-18 UY UY27856A patent/UY27856A1/es not_active Application Discontinuation
- 2003-06-19 TW TW092116667A patent/TW200413329A/zh unknown
- 2003-06-20 AR AR20030102210A patent/AR040445A1/es not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE10227666A1 (de) | 2004-01-08 |
UY27856A1 (es) | 2003-12-31 |
AU2003237945A1 (en) | 2004-01-06 |
JP2006508037A (ja) | 2006-03-09 |
EP1529035A1 (de) | 2005-05-11 |
AR040445A1 (es) | 2005-04-06 |
WO2004000818A1 (de) | 2003-12-31 |
TW200413329A (en) | 2004-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0219876B1 (en) | Antihypertensive agents comprising 2-alkynyladenosines as active ingredients | |
EP3121171B1 (en) | Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine | |
EP2257544B1 (en) | Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts | |
JP4870660B2 (ja) | Cxcr4アンタゴニストの合成プロセス | |
CA2550726A1 (en) | Methods of preparing aripiprazole crystalline forms | |
SK212001A3 (en) | Thiobenzimidazole derivatives | |
HU187773B (en) | Process for preparing substituted imidazole derivatives maceutical compositions containing such compounds | |
CZ20031538A3 (cs) | Substituované 2-anilinobenzimidazoly a farmaceutické prostředky, které je obsahují | |
CA2365118A1 (en) | Inhibitor against human chymase activity | |
NZ197101A (en) | 4,5-dihydro-1,2,4-triazolo(4,3-a)quinoxalin-4-ones | |
AU2006319984B2 (en) | Acid addition salt of optically active dihydropyridine derivative | |
US5387684A (en) | Isoindazole compound | |
CA2485545A1 (en) | (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition | |
US9095585B2 (en) | Bioavailable compositions of amorphous piperidinyl compounds | |
US7169934B2 (en) | (R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition | |
US20080076934A1 (en) | (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition | |
US4261896A (en) | 1-Substituted-2-(substituted-imino)-1H-1,2-dihydrobenz[cd]indoles | |
JPH11506753A (ja) | 平滑筋細胞増殖の阻害薬としてのスチリルベンゾイミダゾール誘導体 | |
US20040162311A1 (en) | Benzimidazole derivative | |
EP0111397A1 (en) | Isoindole derivatives, preparation, and uses | |
US4581460A (en) | Substituted 1-benzoyl-2-phenyliminoimidazolidine derivatives | |
JPH02124885A (ja) | イミダゾール抗不整脈剤 | |
AU675035B2 (en) | Benzene derivatives and pharmaceutical composition | |
JP2001199983A (ja) | ベンズイミダゾール誘導体 | |
CA2436265A1 (en) | 3-(3-amidinophenyl)-5-[({[1-(1-iminoethyl)-4-piperidyl]methyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |